Abstract:Opioids are highly effective analgesics, however, their therapeutic use is limited by adverse effects that include respiratory depression, dependence, and tolerance. Inflammation has been implicated as a significant driver for the development of tolerance to opioids. Recent studies show that chronic morphine in mice results in gut microbial dysbiosis and inflammation in the colon. In the present study, we examined whether colonic inflammation results in tolerance to the antinociceptive effects of morphine. Colonic inflammation was induced in mice by intrarectal administration of 2,4,6-trinitro-benzene sulfonic acid. The development of antinociceptive tolerance was determined by warm-water tail-immersion assay in mice implanted with 25-, 50-, or 75-mg morphine pellet. Colonic inflammation significantly enhanced the rate at which tolerance developed in each cohort of chronic morphine-treated mice. At the lowest dose of morphine pellet (25 mg), antinociceptive tolerance only developed in the presence of colonic inflammation, whereas in 50- and 75-mg pelleted mice, tolerance developed faster in the inflamed animals than in the noninflamed mice. The enhanced antinociceptive tolerance was attenuated with daily administration of peripheral opioid receptor antagonist, 6 beta-N-heterocyclic-substituted naltrexamine derivative 17-cyclopropyInnethyl-3,14 beta-dihydroxy-4,5 alpha-epoxy-6 beta-[(4'pyridyl) acetamido]nnorphinan (NAP)], irrespective of colonic inflammation. Collectively, these findings show that the rate of tolerance to morphine antinociception is exaggerated in the presence of colonic inflammation, and tolerance is prevented by a peripheral mu-opioid receptor antagonist. These studies suggest a peripheral component to the development of antinociceptive tolerance to opioids. Furthermore, peripherally selective opioid antagonists may be useful adjuncts in opioid-based pain management. SIGNIFICANCE STATEMENT This study supports the notion that inflammation influences the development of antinociceptive tolerance to chronic morphine exposure. We found that, in the presence of colonic inflammation, the rate of development of tolerance to the antinociceptive effects of morphine increased. We also found that treatment with a peripheral opioid receptor antagonist prevented morphine antinociceptive tolerance. Increasing opioid intake during an inflammatory state would result in decreased analgesia and enhanced analgesic tolerance, which puts patients with inflammatory bowel diseases, inflammatory joint diseases, and sickle cell anemia at risk for heavy opioid use.

Morphine Potentiates Lps-Induced Autophagy Initiation but Inhibits Autophagosomal Maturation in Murine Macrophages Through Tlr4 Dependent and Independent Signaling

Inhibition of SNAP-25 Phosphorylation at Ser187 is Involved in Chronic Morphine-induced Down-regulation of SNARE Complex Formation

Altered Membrane Expression and Function of CD11b Play a Role in the Immunosuppressive Effects of Morphine on Macrophages at the Nanomolar Level

Activation of spinal PDGFRβ in microglia promotes neuronal autophagy via p38 MAPK pathway in morphine-tolerant rats

Morphine Enhances LPS-induced Macrophage Apoptosis Through a PPARγ-dependent Mechanism.

Morphine induces inflammatory responses via both TLR4 and cGAS-STING signaling pathways

Morphine Disrupts Interleukin-23 (Il-23)/Il-17-mediated Pulmonary Mucosal Host Defense Against Streptococcus Pneumoniae Infection.

Morphine Suppresses IFN Signaling Pathway and Enhances AIDS Virus Infection

Immunosuppressive effects of morphine on macrophage polarization and function

Morphine worsens the severity and prevents pancreatic regeneration in mouse models of acute pancreatitis

Autophagy in Superficial Spinal Dorsal Horn Accelerates the Cathepsin B-dependent Morphine Antinociceptive Tolerance.

Morphine Activates Neuroinflammation In A Manner Parallel To Endotoxin

Morphine-induced macrophage apoptosis modulates migration of macrophages: use of in vitro model of urinary tract infection

Morphine-induced RACK1-dependent Autophagy in Immortalized Neuronal Cell Lines

Morphine Induced Exacerbation of Sepsis is Mediated by Tempering Endotoxin Tolerance Through Modulation of Mir-146A

Experimental Colitis Enhances the Rate of Antinociceptive Tolerance to Morphine Via Peripheral Opioid Receptors

Toll-Like Receptor 9 Is Required For Opioid-Induced Microglia Apoptosis

Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model

Chronic Morphine Treatment Increased the Expression of Myeloid Differentiation Primary Response Protein 88 in Rat Spinal Cord

Morphine induces Beclin 1- and ATG5-dependent autophagy in human neuroblastoma SH-SY5Y cells and in the rat hippocampus.

Morphine promotes microglial activation by upregulating the EGFR/ERK signaling pathway